Cardiovascular Updates from AHA Congress 2024
Cardiometabolic Health Congress
DECEMBER 5, 2024
OPTION Trial : LAAC after AFib ablation was associated with lower risks of major bleeding compared to oral anticoagulation. Earn 14 CME credits anytime on any device. SUMMIT Trial : Weekly subcutaneous tirzepatide showed significant reductions in CV death and HF-related events among patients with HFpEF and obesity. View the study.
52 
Let's personalize your content